Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

154 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Completed

Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM

NCT01816230

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +18 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Loyola University, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Steven and Alexandra Cohen Children's Medical Center New York, United States
View all 15 locations
View Trial Details
Completed

Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

NCT02212561

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +17 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer

NCT02391480

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Breast Cancer, +47 more
Locations
  • Scottsdale Healthcare /ID# 132963 Scottsdale, Arizona, United States
  • City of Hope /ID# 154053 Duarte, California, United States
  • UC Davis Comp Cancer Ctr /ID# 154644 Sacramento, California, United States
  • Yale University /ID# 136982 New Haven, Connecticut, United States
View Trial Details
Completed

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

NCT01929408

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • University of Maryland Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation

NCT01237808

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Ubbo-Emmius Klinik Aurich Aurich, Germany
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • University Hospital of Bonn Bonn, Germany
  • Städtisches Klinikum Braunschweig Braunschweig, Germany
View all 33 locations
View Trial Details

Related conditions